Home Your basket
• Middle ear adenoma / carc...
   Price 8.50 €
• Brain stem cavernous angi...
   Price 8.50 €
• Validation of a self-asse...
   Price 10.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Exploration of the swallo...
   Price 14.00 €
• Parry-Romberg syndrome as...
   Price 12.50 €
• ...
   Price 5.50 €
• "Endolymphatic" cochleo-v...
   Price 10.50 €
• Acoustic study of sustain...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Nasal polyposis and olfac...
   Price 10.50 €
• Salivary gland choristoma...
   Price 5.50 €
• Contribution of endoscopi...
   Price 8.50 €
• Local anesthesia for coch...
   Price 8.50 €
• Persistent stapedial arte...
   Price 5.50 €
• The prevention of voice d...
   Price 10.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• Evaluation of the primary...
   Price 5.50 €
• Endoscopic medialization ...
   Price 8.50 €
• Ambulatory stapedectomy: ...
   Price 8.50 €
• Paraganglioma of the cere...
   Price 5.50 €
• Surgical exploration of t...
   Price 10.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Today’s importance of ult...
   Price 14.00 €
• Schwannoma of the postcri...
   Price 5.50 €
• Parapharyngeal tumours: M...
   Price 10.50 €
• Anosmia following superio...
   Price 5.50 €
• When to suspect a perilym...
   Price 10.50 €
• Treatment of severe epist...
   Price 5.50 €
• Extraction of the esophag...
   Price 8.50 €
• A detailed examination of...
   Price 10.50 €
• A new technique for the u...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Advantages of combined th...
   Price 10.50 €

Total Order 331.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE